Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
IBEW - NECA LOCAL 505 HEALTH & WELFARE PLAN v. SMITHKLINE BEECHAM CORPORATION
Case Number:
2:08-cv-03301
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Arnold & Porter
- Bailey & Glasser
- Ballard Spahr
- Bolognese & Associates
- Chimicles Schwartz
- Girard Sharp
- Grabar Law
- Grant & Eisenhofer
- Herzfeld Suetholz
- Joseph Saveri Law Firm
- Kessler Topaz
- Lieff Cabraser
- Motley Rice
- Sauder Schelkopf
- Schnader Harrison
- Shub & Johns
- Stranch Jennings
- Wexler Boley
- Zelle LLP
-
June 19, 2013
Judge Gives Final OK To $35M GSK Flonase Settlement
A Pennsylvania federal judge Wednesday gave final approval to a $35 million settlement ending a class action alleging GlaxoSmithKline PLC used improper means to block its rivals from bringing generic versions of its allergy medication Flonase to market.
-
May 24, 2013
Flonase Users Seek Sanctions For Foes Of $35M Antitrust Deal
Flonase purchasers urged a Pennsylvania federal court Thursday to sanction objectors to a $35 million class action settlement of allegations that GlaxoSmithKline PLC improperly delayed market entry of a generic nasal spray, saying the two objectors and their attorneys ignored a court order.
-
January 15, 2013
GSK's Generic Flonase Antitrust Deal Gets Green Light
A Pennsylvania federal judge on Monday approved a settlement between GlaxoSmithKline PLC and two groups of plaintiffs in an antitrust class action accusing the pharmaceutical giant of improperly blocking rivals from bringing generic versions of allergy medication Flonase to market.
-
November 01, 2012
Ex-FDA Head To Testify In GSK Flonase Antitrust Row
A Pennsylvania federal judge struck a blow to GlaxoSmithKline PLC on Thursday, ruling that plaintiffs in a class action accusing it of illegally blocking development of a generic Flonase could tap former U.S. Food and Drug Administration chief David Kessler as an expert witness.
-
June 19, 2012
Judge Certifies Limited Class In Flonase Antitrust Action
A Pennsylvania federal judge certified a limited class of indirect purchasers of Flonase in five states on Monday as part of a suit accusing GlaxoSmithKline PLC of improperly blocking rivals from bringing generic versions of the nasal spray to market.
-
September 26, 2011
Funds' Flonase Antitrust Suit Survives GSK Dismissal Bid
A Pennsylvania federal judge on Monday issued a split ruling on GlaxoSmithKline PLC's bid for summary judgment in four health care funds' antitrust class action alleging it improperly delayed sales of a generic version of Flonase, striking some claims while keeping others alive.
-
June 02, 2011
GSK Denied Quick Win In Flonase Antitrust Cases
GlaxoSmithKline PLC on Thursday lost a bid for summary judgment in three antitrust cases pending in Pennsylvania that allege the company delayed sales of a generic version of Flonase by filing baseless petitions with the U.S. Food and Drug Administration.